Selected Key Figures*

The fiscal year of HELLA ends on May 31.

* Please observe the remarks on the Yearly Figures.

Yearly figures

in € million	2015/2016	2014/2015	2013/2014
Sales	6,352	5,835	5,343
Change compared to last year	9%	9%	11%
Adjusted EBITDA*	858	781	708
Change compared to last year	10%	10%	25%
Adjusted EBIT*	476	445	399
Change compared to last year	7%	12%	30%
Consolidated profit	272	295	230
Change compared to last year	-8%	29%	12%
R&D expenses	623	544	514
Change compared to last year	15%	6%	16%
Cash flow from operating activities	602	560	535
Change compared to last year	8%	5%	21%
Net capital expenditures^**	463	347	368
Change compared to last year	33%	-6%	-14%
Net debt	238	131	425
Change compared to last year	82%	-69%	3%
Permanent Employees (headcount, on average; not in € million)	32,708	31,484	29,560
Change compared to last year	4%	7%	7%

Adjusted EBITDA margin*	13.5%	13.4%	12.3%
Adjusted EBIT margin*	7.5%	7.6%	7.5%
R&D expenses in relation to sales	9.8%	9.3%	9.6%
Net debt/EBITDA (share)	0.3x	0.2x	0.6x
Equity ratio	39.6%	38.8%	30.1%
Return on equity	14.2%	22.0%	19.0%

* Adjusted for special items from the loss of a supplier in China (€ 47 million) as well as for costs incurred in conjunction with the voluntary partial and severance payment programme (€ 9 million). For further information on the adjusted non-recurring charges, please refer to the current and prior financial statements.
** Settlements for capital expenditures balanced with cash inflows from customer refunds

Nine Month Figures

in € million	Nine Months FY 2016/2017	Nine Months FY 2015/2016
Sales	4,776	4,654
Change compared to previous period [curency- and portfolio adjusted]	3% [4%]	10% [8%]
EBIT [adjusted]	348 [373]	290 [345]
Change compared to previous period	20% [8%]	-6% [9%]
EBITDA	641	582
Change compared to previous period	10%	6%
Earnings for the period	248	184
Change compared to previous period	35%	-15%
Earnings per share (in €)	2.21	1.63
Change compared to previous period	35%	-19%
R&D expenses	468	449
Change compared to previous period	4%	11%
Free cashflow [adjusted]	9 [86]	-10 [56]
Net capital expenditure	328	297
Change compared to previous period	10%	16%

EBIT margin [adjusted]	7.3% [7.8%]	6.2% [7.4%]
EBITDA margin	13.4%	12.5%
R&D expenses in relation to sales	9.8%	9.6%
Net financial debt	317	300
Net financial debt/EBITDA (last 12 months)	0.4x	0.4x
Equity ratio	42.3%	39.1%
Return on equity (last 12 months)	17.7%	14.7%
Number of employees (headcount; not in € million)	36,068	33,023

Further information can be found in the financial information for the quarter and in the further notes.

Quarterly figures

in € million	3^rd quarter FY 2016/2017	3^rd quarter FY 2015/2016
Sales	1,578	1,495
Change compared to previous period [curency- and portfolio adjusted]	6% [6%]	7% [7%]
EBIT [adjusted]	103 [105]	87 [89]
Change compared to previous period	18% [17%]	-1% [-2%]
EBITDA	203	182
Change compared to previous period	11%	8%
Earnings for the period	74	53
Change compared to previous period	41%	-19%
Earnings per share (in €)	0.65	0.47
Change compared to previous period	38%	-16%
R&D expenses	157	157
Change compared to previous period	0%	15%
Free cashflow [adjusted]	16 [19]	-63 [-39]
Net capital expenditure	120	108
Change compared to previous period	11%	73%